Filtered By:
Cancer: Head and Neck Cancer

This page shows you your search results in order of date.

Order by Relevance | Date

Total 17 results found since Jan 2013.

Mind-Body Therapies in the Management of Otolaryngologic Disease: A State-of-the-Art Review of Randomized Controlled Trials
CONCLUSION: RCTs of MBTs, including breathing exercises (4), aromatherapy (2), biofeedback (2), meditation, (2), and yoga (2), have been studied in several otolaryngologic conditions, including septoplasty/rhinoplasty (3), head and neck cancer (2), facial palsy (2), and tinnitus (2). Most studies were of moderate risk of bias on appraisal, and each MBT studied was found to significantly reduce subjective and objective distress associated with the otolaryngologic condition in question.IMPLICATIONS FOR PRACTICE: Despite a paucity of strong evidence supporting the universal use of MBTs, our review suggests that MBTs are cost-...
Source: Cancer Control - September 15, 2023 Category: Cancer & Oncology Authors: Dhruv S Kothari Chad A Nieri Zachary G Tanenbaum Lauren A Linker Sanjeet V Rangarajan Source Type: research

Hearing screening and amplifier uptake results in a multidisciplinary head and neck cancer survivorship clinic
ConclusionsThe data from 1176 survivors of HNC seen by audiology over the past few years as part of the UPMC HNC Survivorship Clinic support the need for hearing management in this population to improve communication during and after the Survivorship Clinic visit.Implications for Cancer SurvivorsSurvivors of HNC have a high prevalence of greater than mild hearing loss and tinnitus (both issues known to negatively impact health-related communication and quality of life). This manuscript describes a hearing screening program within a Survivorship Clinic that identifies individuals in need of non-custom amplification during t...
Source: Journal of Cancer Survivorship - May 25, 2023 Category: Cancer & Oncology Source Type: research

Risk factors associated with cisplatin ‐induced ototoxicity in Japanese patients with solid tumors
ConclusionNo patient discontinued treatment owing to hearing impairment. The total cisplatin dose was considered related to post-treatment hearing impairment frequency in Japanese patients. However, routine audiometric monitoring is recommended during high-dose cisplatin-based chemotherapy.
Source: Cancer Medicine - December 26, 2022 Category: Cancer & Oncology Authors: Hideaki Okada, Koichi Kitagawa Tags: RESEARCH ARTICLE Source Type: research

Association of hearing loss and tinnitus symptoms with health ‐related quality of life among long‐term oropharyngeal cancer survivors
ConclusionsOur findings provide preliminary evidence to support the need for continued audiological evaluations and surveillance to detect hearing dysfunction, to allow for early management and to alleviate the long-term impact on QoL.
Source: Cancer Medicine - June 13, 2022 Category: Cancer & Oncology Authors: Puja Aggarwal, Marc ‐Elie Nader, Paul W. Gidley, Raj Pratihar, Shirin Jivani, Adam S. Garden, Frank E. Mott, Ryan P. Goepfert, Christopher Wallace Ogboe, Camille Charles, Clifton D. Fuller, Stephen Y. Lai, G. Brandon Gunn, Erich M. Sturgis, Tags: RESEARCH ARTICLE Source Type: research

Final Report of NRG Oncology RTOG 0022: A Phase I/II Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer
CONCLUSION: NRG/RTOG 0022 was the first trial testing the feasibility of IMRT in a multi-institutional setting. In addition to meeting the criteria for acceptable local-regional control and reduction in acute xerostomia, long-term outcomes were very good with few deaths attributed to the studied cancer, 2/3 of patients alive at 10 years, and few grade 3-4 toxicities. Since conduct of this study, further improvements in IMRT have been accomplished both with regards to technical advancements in treatment delivery as well as attention to additional avoidance structures beyond the parotid glands. IMRT has transitioned from an ...
Source: Ann Oncol - October 27, 2021 Category: Cancer & Oncology Authors: A S Garden J Harris A Eisbruch K S C Chao W H Morrison P M Harari T A Swanson C U Jones S S Yom S A Spencer R A Scrimger G Shenouda M E Shukla H Lau M L Mierzwa P Torres-Saavedra Q T Le Source Type: research

Generalizability assessment of head and neck cancer NTCP models based on the TRIPOD criteria.
Abstract This review aimed to provide an overview of the level of maturity of normal tissue complication probability (NTCP) models for head and neck cancer (HNC) patients. A systematic literature review was performed to retrieve NTCP models for HNC toxicities. Patient population characteristics, NTCP model and the predictors, treatment technique and endpoint definition were extracted per article. Models were then scored based on the TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) consensus guidelines to evaluate their generalizability. 335 articles on photon...
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 6, 2020 Category: Radiology Authors: Sharabiani M, Clementel E, Andratschke N, Hurkmans C Tags: Radiother Oncol Source Type: research

Middle ear adenoma with neuroendocrine differentiation: Report of a rare case
We present a case report of MEA-ND in a 24-year-old woman who presented with heaviness and tinnitus in the right ear.
Source: Indian Journal of Cancer - February 25, 2020 Category: Cancer & Oncology Authors: Shakti Kumar Yadav Roshina Naeem Amitabh Sharma Sompal Singh Namrata Sarin Sonam Kumar Pruthi Source Type: research

Symptom distress and interference among cancer patients with osteoradionecrosis of jaw: A cross-sectional study
ConclusionsORNJ patients suffered mainly from limited mouth opening and other maxillofacial symptoms. The problem of limited mouth opening was more severe in patients with longer time to onset of ORNJ after radiotherapy. ORNJ patients commonly had symptom distress, which influenced their quality of life.
Source: International Journal of Nursing Sciences - June 4, 2019 Category: Nursing Source Type: research

What is the evidence for cannabis use in otolaryngology?: A narrative review
ConclusionFurther research is required to determine the potential therapeutic roles and adverse effects of cannabis on conditions related to Otolaryngology. This study serves the Otolaryngological researcher with the most current, comprehensive literature review for the exploration into possible projects to undertake.
Source: American Journal of Otolaryngology - May 30, 2019 Category: Endocrinology Source Type: research

Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study
Conclusion: The studies have shown hearing loss in higher frequencies, but in our study, we have observed hearing loss at speech frequency in 22.2% of patients receiving cisplatin, who also had low serum albumin levels. Periodic audiometric monitoring and serum albumin level may be helpful to provide timely intervention to prevent further hearing loss and deterioration in the quality of life.
Source: Journal of Cancer Research and Therapeutics - September 7, 2018 Category: Cancer & Oncology Authors: Balamurali Kalyanam N Sarala SM Azeem Mohiyuddin Ravi Diwakar Source Type: research

Protontherapy of head and neck paragangliomas: A monocentric study.
CONCLUSION: Proton beam therapy is an effective and well-tolerated treatment modality of skull base paragangliomas, with documented functional benefit. A longer follow-up is planned in order to assess local control and long-term toxicities. PMID: 29269165 [PubMed - as supplied by publisher]
Source: Cancer Radiotherapie - December 18, 2017 Category: Cancer & Oncology Authors: Cao KI, Feuvret L, Herman P, Bolle S, Jouffroy T, Goudjil F, Amessis M, Rodriguez J, Dendale R, Calugaru V Tags: Cancer Radiother Source Type: research

Eagle Syndrome Secondary to Osteoradionecrosis of the Styloid Process.
CONCLUSION: Radiation is a common component of treatment for head and neck cancers. The diagnosis of Eagle syndrome secondary to osteoradionecrosis of the styloid process is an elusive, but important, diagnosis to consider because the condition can be treated successfully. PMID: 28638295 [PubMed - in process]
Source: Ochsner Journal - June 24, 2017 Category: General Medicine Tags: Ochsner J Source Type: research

Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients
Low level laser therapy (LLLT) was first introduced for potential clinical applications by Mester in the late 1960s. This form of laser treatment, currently referred to as photobiomodulation (PBM), limits radiation intensity by transferring low energy to tissues and thereby does not generate heat. Among the clinical indications for which LLLT has been reported to be efficacious are pain relief (back and neck, orthodontic, shoulder), wound healing, carpal tunnel syndrome, colorectal cancer, elbow disorders, fibromyalgia, lymphedema, musculoskeletal dysfunction, myofascial pain syndrome, neurological dysfunctions, patella-fe...
Source: Oral Oncology - February 3, 2016 Category: Cancer & Oncology Authors: Stephen T. Sonis, Sepehr Hashemi, Joel B. Epstein, Raj G. Nair, Judith E. Raber-Durlacher Tags: Review Source Type: research

A mutation of the succinate dehydrogenase B gene in a Korean family with paraganglioma
We report a case of germline SDHB mutation. This mutation was a deletion of thymine at nucleotide position 757 in exon 7 of the SDHB gene (c.757delT).
Source: Familial Cancer - February 1, 2016 Category: Cancer & Oncology Source Type: research

Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy
Abstract Head and neck cancer patients treated with high-dose cisplatin and radiotherapy will suffer from hearing deficits. The current low-dose regimen seldom causes hearing threshold decrease. Tinnitus in this patient population has not been investigated earlier. We aimed to evaluate the possible ototoxicity of low-dose (40 mg/m2) weekly administered cisplatin with concomitant radiotherapy. Twenty-two patients with locally advanced head and neck cancer were prospectively recruited to participate the study after treatment recommendation for chemoradiotherapy with low-dose cisplatin and intensity-modulated radiot...
Source: European Archives of Oto-Rhino-Laryngology - December 21, 2015 Category: ENT & OMF Source Type: research